KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Change in Receivables (2016 - 2025)

Historic Change in Receivables for LifeMD (LFMD) over the last 14 years, with Q3 2025 value amounting to -$76396.0.

  • LifeMD's Change in Receivables fell 10158.11% to -$76396.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.2 million, marking a year-over-year decrease of 13690.02%. This contributed to the annual value of $4.6 million for FY2024, which is 8785.36% up from last year.
  • LifeMD's Change in Receivables amounted to -$76396.0 in Q3 2025, which was down 10158.11% from -$2.0 million recorded in Q2 2025.
  • Over the past 5 years, LifeMD's Change in Receivables peaked at $4.8 million during Q3 2024, and registered a low of -$2.0 million during Q2 2025.
  • In the last 5 years, LifeMD's Change in Receivables had a median value of $381152.0 in 2021 and averaged $399802.4.
  • Its Change in Receivables has fluctuated over the past 5 years, first skyrocketed by 296250.87% in 2023, then tumbled by 70377.61% in 2025.
  • LifeMD's Change in Receivables (Quarter) stood at -$986755.0 in 2021, then skyrocketed by 164.33% to $634825.0 in 2022, then surged by 35.26% to $858668.0 in 2023, then tumbled by 173.86% to -$634211.0 in 2024, then soared by 87.95% to -$76396.0 in 2025.
  • Its Change in Receivables stands at -$76396.0 for Q3 2025, versus -$2.0 million for Q2 2025 and $467855.0 for Q1 2025.